Our approach to treating food allergies is to develop a targeted therapy that reduces the potential for a severe anaphylactic reaction from accidental exposure.

We believe by targeting the delivery of the drug to the immune cells in the skin we can offer a meaningful treatment while minimizing the risk of side effects. 

We target the drug to the skin’s immune cells using Moonlight’s proprietary platform: TASIS. This involves application of a small, minimally invasive dermal stamp that uses microneedles. The stamp is removed within a few minutes and the administration is complete.

Our first treatment is for peanut allergy.